These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9746028)

  • 1. p53 mutations in BRCA1-associated familial breast cancer.
    Schlichtholz B; Bouchind'homme B; Pagés S; Martin E; Liva S; Magdelenat H; Sastre-Garau X; Stoppa-Lyonnet D; Soussi T
    Lancet; 1998 Aug; 352(9128):622. PubMed ID: 9746028
    [No Abstract]   [Full Text] [Related]  

  • 2. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
    Greenblatt MS; Chappuis PO; Bond JP; Hamel N; Foulkes WD
    Cancer Res; 2001 May; 61(10):4092-7. PubMed ID: 11358831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor suppressor genes and breast cancer.
    Buchholz TA; Weil MM; Story MD; Strom EA; Brock WA; McNeese MD
    Radiat Oncol Investig; 1999; 7(2):55-65. PubMed ID: 10333246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
    Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
    Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region.
    Zelada-Hedman M; Wasteson Arver B; Claro A; Chen J; Werelius B; Kok H; Sandelin K; Håkansson S; Andersen TI; Borg A; Børresen Dale AL; Lindblom A
    Cancer Res; 1997 Jun; 57(12):2474-7. PubMed ID: 9192828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
    Couch FJ; DeShano ML; Blackwood MA; Calzone K; Stopfer J; Campeau L; Ganguly A; Rebbeck T; Weber BL
    N Engl J Med; 1997 May; 336(20):1409-15. PubMed ID: 9145677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BRCA1 mutations in a Pakistani family with hereditary breast and ovarian cancer syndrome.
    Moslehi R; Solehdin F; Malik I; Narod S
    Am J Med Genet; 1998 Jul; 78(4):386-7. PubMed ID: 9714446
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Mol Carcinog; 2010 Jun; 49(6):545-55. PubMed ID: 20306497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a recurrent BRCA1 mutation in German breast-cancer and/or ovarian-cancer families.
    Hofmann W; Jandrig B; Classen E; Nestle-Kraemling C; Chang-Claude J; Scherneck S
    J Cancer Res Clin Oncol; 2001; 127(3):200-2. PubMed ID: 11260866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New method predicts risk of breast-ovarian cancer gene mutations.
    Int J Fertil Womens Med; 1997; 42(6):405. PubMed ID: 9459083
    [No Abstract]   [Full Text] [Related]  

  • 19. BRCA1 polymorphisms.
    Campbell IG; Schroff R; Englefield P; Eccles DM
    Br J Cancer; 1997; 75(12):1854-5. PubMed ID: 9192995
    [No Abstract]   [Full Text] [Related]  

  • 20. [Germ-line mutations of the BRCA1 gene in northeastern France].
    Fricker JP; Muller D; Cutuli B; Rodier JF; Janser JC; Jung GM; Mors R; Petit T; Haegele P; Abecassis J
    Bull Cancer; 2000 Oct; 87(10):739-44. PubMed ID: 11084537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.